Tilray Brands Reports Wider-Than-Expected Q1 Fiscal 2027 Loss

Key Facts

1Tilray reported a loss of $0.32 per share, wider than the estimated loss of approximately $0.18.

2Revenue reached $257.10 million, missing the analyst estimate of $266.30 million.

3The company achieved 23% year-over-year revenue growth with gross margins improving to 30%.

Tilray Brands reported a loss of $0.32 per share for its first quarter of fiscal 2027, wider than the analyst estimate of approximately $0.18. According to Financial Modeling Prep, revenue reached $257.10 million, missing the expected $266.30 million. The earnings miss was attributed to challenges in the Canadian cannabis market and pricing pressures, although growth in international medical cannabis and beverage segments provided some offset.

The company achieved a 23% year-over-year revenue growth, with gross margins improving to 30%. TLRY closed at $3.72 on October 7, 2026, prior to the earnings release which also noted a $42 million reduction in outstanding debt fiscal year-to-date. Revenue in the Europe, Middle East, and Africa region increased by 71%, led by medical cannabis and pharmaceutical distribution.